These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32108545)

  • 61. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
    Rebegea L; Firescu D; Dumitru M; Anghel R
    Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
    Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Self-Managed Surveillance for Breast Cancer-Related Upper Body Issues: A Feasibility and Reliability Study.
    Rafn BS; Singh CA; Midtgaard J; Camp PG; McNeely ML; Campbell KL
    Phys Ther; 2020 Mar; 100(3):468-476. PubMed ID: 32043126
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
    Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Axillary reverse mapping in breast cancer: a Canadian experience.
    Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
    J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
    Gauthier T; Garuchet-Bigot A; Marin B; Mollard J; Loum O; Fermeaux V; Jammet I; Kanoun D; Maubon A; Aubard Y
    Eur J Surg Oncol; 2012 Oct; 38(10):902-9. PubMed ID: 22703757
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery.
    Sagen A; Kåresen R; Skaane P; Risberg MA
    Arch Phys Med Rehabil; 2009 May; 90(5):803-9. PubMed ID: 19406300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].
    Gobardhan PD; Klompenhouwer EG; Beek MA; Voogd AC; Luiten EJ
    Ned Tijdschr Geneeskd; 2013; 157(22):A5646. PubMed ID: 23714290
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety of elective hand surgery following axillary lymph node dissection for breast cancer.
    Hershko DD; Stahl S
    Breast J; 2007; 13(3):287-90. PubMed ID: 17461904
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The need for lymph node dissection in nonmetastatic breast cancer.
    Pesce C; Morrow M
    Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A new technique that complements sentinel lymph node biopsy: lymph node dissection under the intercostobrachial nerves in early-stage breast cancer.
    Li J; Jia S; Zhang W; Zhang Y; Qiu F; Xue J; Gu X
    Clin Breast Cancer; 2013 Jun; 13(3):212-8. PubMed ID: 23380290
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
    McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current rehabilitation processes do not prevent long-term impairments after treatment for breast cancer in Australia.
    Dylke ES; Kilbreath S
    Aust Fam Physician; 2015 Jun; 44(6):405-9. PubMed ID: 26209993
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
    Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries.
    Abass MO; Gismalla MDA; Alsheikh AA; Elhassan MMA
    J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30281378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
    Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
    Nielsen HM; Friis RB; Linnet S; Offersen BV
    Acta Oncol; 2017 May; 56(5):713-718. PubMed ID: 28105873
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
    Iyigun ZE; Duymaz T; Ilgun AS; Alco G; Ordu C; Sarsenov D; Aydin AE; Celebi FE; Izci F; Eralp Y; Ozmen V
    Lymphat Res Biol; 2018 Feb; 16(1):28-35. PubMed ID: 28346852
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors.
    Terada M; Yoshimura A; Sawaki M; Hattori M; Naomi G; Kotani H; Adachi Y; Iwase M; Kataoka A; Sugino K; Mori M; Horisawa N; Ozaki Y; Iwata H
    Breast Cancer Res Treat; 2020 Jan; 179(1):91-100. PubMed ID: 31535321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.